Australia's Island Pharma hits 6-1/2-month high on Canadian patent
16/11/2022 03:19
** Shares of Australia's Island Pharmaceuticals Ltd ILA.AX
rise as much as 7.9% to A$0.205, highest since May 2
** Anti-viral drug developer says co has been granted patent
relating to drug ISLA-101 by the Canadian Intellectual Property
Office
** ISLA-101 is an anti-viral drug used to treat different
mosquito bone virus
** ILA stock had fallen 25.5% this year, as of last close
(Reporting by Nausheen Thusoo)
((Nausheen.Thusoo@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic